Does RIVAROXABAN Cause Neoplasm malignant? 336 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 336 reports of Neoplasm malignant have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.3% of all adverse event reports for RIVAROXABAN.
336
Reports of Neoplasm malignant with RIVAROXABAN
0.3%
of all RIVAROXABAN reports
59
Deaths
70
Hospitalizations
How Dangerous Is Neoplasm malignant From RIVAROXABAN?
Of the 336 reports, 59 (17.6%) resulted in death, 70 (20.8%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 336 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RIVAROXABAN Alternatives Have Lower Neoplasm malignant Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM